San Francisco, CA · Founded 2016 · Privately Held (backing)
Developer of genetically engineered probiotics designed to improve the body's ability to break down unwanted byproducts of alcohol to convert sugar into fiber in the gut. ZBiotics is based in San Francisco, CA and was founded in 2016. It was valued at $67 million at its later-stage round in Aug 2024, the last priced event on record. It has raised $40.3 million across 2 recorded rounds; the latest was a $22.4 million early-stage round in Mar 2024.
PMV mark · valuation
$67.0M
Oct 2026
Priced at
its later-stage round
Aug 2024
Total raised
$40.3M
Last round
Early Stage VC
Mar 2024
Cap table — not yet on record
ZBiotics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ZBiotics with a free account
·The complete investor list: 34 names
·Watch ZBiotics: the Monday email on marks, rounds and moves